A healthcare company based out of Pennsylvania caused quite the stir on Tuesday after the company announced that it had entered into an exclusive license agreement with Biosion...

To read the full story on AllPennyStocks.com, click here.

Grafico Azioni Aclaris Therapeutics (NASDAQ:ACRS)
Storico
Da Feb 2025 a Mar 2025 Clicca qui per i Grafici di Aclaris Therapeutics
Grafico Azioni Aclaris Therapeutics (NASDAQ:ACRS)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di Aclaris Therapeutics